Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers present nanoencapsulated hepatocyte enzymes to fight alcohol intoxication

May 11, 2018

Phase I study of AVB-S6-500 demonstrates proof of mechanism

May 11, 2018

FDA identifies deficiencies during NDA review of Methylene Blue MMX

May 11, 2018

Lilly to acquire ARMO BioSciences

May 11, 2018

Phosphodiesterase PDE4 inhibitors patented byTakeda

May 11, 2018

MFN2 agonist restores mitochondrial trafficking in models of Charcot-Marie-Tooth disease type 2A

May 11, 2018

Pharmasum Therapeutics identifies novel DYRK inhibitors

May 11, 2018

Novel PTP-2C inhibitors discovered at DE Shaw Research, Relay Therapeutics

May 11, 2018

Patient recruitment ongoing in phase I trial of PF-06821497

May 11, 2018

Prelude Therapeutics discovers PRMT5 inhibitors

May 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...